TRPC3 is upregulated in numerous cancers and has been proposed to promote tumorigenesis by mediating sustained elevated Ca2+ signalling (Chang et al., 2018; Lin et al., 2021; Shapovalov et al., 2016; Wang et al., 2019; Yang et al., 2009). Here, TRPC3 is linked to cancer.